PACLITAXEL IN OVARIAN-CANCER - HOW CAN WE MAKE IT BETTER

被引：8

作者：

CANNISTRA, SA

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 09期

关键词：

D O I：

10.1200/JCO.1994.12.9.1743

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1743 / 1744

页数：2

相关论文

共 5 条

[1] BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].

HOCKENBERY, D ;

NUNEZ, G ;

MILLIMAN, C ;

SCHREIBER, RD ;

KORSMEYER, SJ .

NATURE, 1990, 348 (6299) :334-336

[2] P53-DEPENDENT APOPTOSIS MODULATES THE CYTOTOXICITY OF ANTICANCER AGENTS [J].

LOWE, SW ;

RULEY, HE ;

JACKS, T ;

HOUSMAN, DE .

CELL, 1993, 74 (06) :957-967

[3] 2ND-LINE PLATINUM THERAPY IN PATIENTS WITH OVARIAN-CANCER PREVIOUSLY TREATED WITH CISPLATIN [J].

MARKMAN, M ;

ROTHMAN, R ;

HAKES, T ;

REICHMAN, B ;

HOSKINS, W ;

RUBIN, S ;

JONES, W ;

ALMADRONES, L ;

LEWIS, JL .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) :389-393

[4]

MCGUIRE WP, 1993, P AN M AM SOC CLIN, V12, P255

[5] PHASE-II TRIAL OF PACLITAXEL IN PATIENTS WITH PROGRESSIVE OVARIAN-CARCINOMA AFTER PLATINUM-BASED CHEMOTHERAPY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].

THIGPEN, JT ;

BLESSING, JA ;

BALL, H ;

HUMMEL, SJ ;

BARRETT, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) :1748-1753